Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study

Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study

header-info
Patients with allogeneic HCT who develop acute respiratory failure are perceived to have worse outcomes than autologous HCT and non-transplant patients with hematologic malignancy.